CytomX Therapeutics' Series B - II Round

CytomX Therapeutics raised a round of funding on July 31, 2012.

CytomX Therapeutics is a biotechnology company developing Probody therapeutics for the treatment of cancer. Probodies are masked antibodies that remain inert in healthy tissue but are activated specif…

Articles about CytomX Therapeutics' Series B - II Round: